Status:
COMPLETED
Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms
Lead Sponsor:
General Biologicals Corporation
Conditions:
Periodontal Diseases
Peri-Implantitis
Eligibility:
All Genders
25+ years
Brief Summary
More than ninety percent of adults in Taiwan are suspected to carry periodontal disease, which causes bad breath, swollen and bleeding gums, plaque and even tooth loss. Half of the patients, however, ...
Eligibility Criteria
Inclusion
- Age≧25
- 3≦periodontal screening and recording≦4
- 16 natural teeths and 6 front teeth at lesat
- GI≧1.25
- PI≧2
Exclusion
- People who have oral lesion, dental braces, denture, mouthwash allergy, or serious systemic disease
- People who have ever eaten antibiotics and Anti-inflammatory drugs over the last 6 months
- People who have ever eaten Immunosuppressive drugs, antiepileptic drugs, antihypertensive drugs, or anticoagulant
- Pregnant women or the woman who eat birth control pills
Key Trial Info
Start Date :
October 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03345329
Start Date
October 1 2015
End Date
September 30 2016
Last Update
November 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.